Search

Displaying results 6011 - 6020 of 10000 in total
  1. Drug

    Myrothecium verrucaria

    go.drugbank.com/drugs/DB10819
    Approved

    Myrothecium verrucaria is a fungus which can provoke allergic reactions. Myrothecium verrucaria extract is used in allergenic testing.

  2. Drug

    Mycocladus corymbiferus

    go.drugbank.com/drugs/DB10839
    Approved

    Mycocladus corymbiferus is a fungus which can provoke allergic reactions. Mycocladus corymbiferus extract is used in allergenic testing.

  3. Drug

    Microsporum audouinii

    go.drugbank.com/drugs/DB10842
    Approved

    Microsporum audouinii is a fungus which can provoke allergic reactions. Microsporum audouinii extract is used in allergenic testing.

  4. Drug

    Tetracoccosporium paxianum

    go.drugbank.com/drugs/DB10849
    Approved

    Tetracoccosporium paxianum is a fungus which can provoke allergic reactions. Tetracoccosporium paxianum extract is used in allergenic testing.

  5. Drug

    Cladosporium herbarum

    go.drugbank.com/drugs/DB10865
    Approved

    Cladosporium herbarum is a fungus which can provoke allergic reactions. Cladosporium herbarum extract is used in allergenic testing.

  6. Drug

    Chrysonilia sitophila

    go.drugbank.com/drugs/DB10935
    Approved

    Chrysonilia sitophila is a fungus which can provoke allergic reactions. Chrysonilia sitophila extract is used in allergenic testing.

  7. Drug

    Aspergillus nidulans

    go.drugbank.com/drugs/DB11022
    Approved

    Aspergillus nidulans is a fungus which can provoke allergic reactions. Aspergillus nidulans extract is used in allergenic testing.

  8. Drug

    Dendryphiella vinosa

    go.drugbank.com/drugs/DB11025
    Approved

    Dendryphiella vinosa is a fungus which can provoke allergic reactions. Dendryphiella vinosa extract is used in allergenic testing.

  9. Drug

    Valdecoxib

    go.drugbank.com/drugs/DB00580
    ApprovedWithdrawn

    Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke.

  10. Drug

    RTN-001

    go.drugbank.com/drugs/DB05615
    Investigational

    SLx-2101 is an oral, long-acting PDE5 inhibitor developed by Surface Logix Inc. to treat Hypertension.